Home / Investors / Fei Shen

Fei Shen

Venture Fund · Cambridge

About Fei Shen

Venture capital investor (Head of BD&L USA & Global TA Inflammation) based in Cambridge, Massachusetts. Focus areas include Health Care, Research and Development, Wellness. Invests at series b, series a stage. Past investments include STRM.BIO, Rgenta Therapeutics Inc., ArrePath.

Investment focus

Stages
Sectors

Portfolio

No portfolio companies recorded yet; Fei Shen reports 3 investments overall.

Similar investors